Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

U.S. revenue in the fourth quarter of 2024 was $91.4 million, a decrease of 9.9% compared with $101.5 million in the prior year period. U.S. permanent implant procedures decreased by 7.0% compared ...

Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to EveryoneSAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), ...

Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases INGELHEIM, Germany and BARCELONA, Spain, March 11, 2025 /PRNewswire/ ...

Collaborating with Intel and NexCOBOT, QNX's safety-certifiable solution delivers enhanced safety and efficiency in AI-powered robotics available on one platform NUREMBERG, GERMANY / ACCESS Newswire / ...

NUREMBERG, GERMANY / / March 10, 2025 / QNX, a division of BlackBerry Limited (NYSE:BB)(TSX:BB) today announced the launch of its QNX® General Embedded Development Platform (GEDP), designed to ...

Calix accelerates SmartBiz deployments, enabling support for more types of small businesses like medical clinics and dental practices ... --(BUSINESS WIRE)--Calix, Inc. (NYSE: CALX) announced ...

Feb. 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies ... Teleflex, the Teleflex logo, Arrow, Barrigel, Deknatel, LMA, Pilling, QuikClot ...

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at ...

Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...